Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Carl Shanholtz"'
Autor:
Cheryl Dennison Himmelfarb, Victor D. Dinglas, Alison E. Turnbull, Hongkai Ji, Pedro A. Mendez-Tellez, Ramona O. Hopkins, Megan M. Hosey, Albert W. Wu, Dale M. Needham, Carl Shanholtz
Publikováno v:
Chest. 161:407-417
Background Perceived health is one of the strongest determinants of subjective well-being, but it has received little attention among survivors of ARDS. Research question How well do self-reported measures of physical, emotional, and social functioni
Autor:
Lyndsay M. O’Hara, Carl Shanholtz, Michael J Armahizer, Surbhi Leekha, Jessica P. Brown, Blaine Kenaa, Mary Richert
Publikováno v:
Infection Control & Hospital Epidemiology. 43:284-290
Background:Prompt diagnosis and intervention for ventilator-associated pneumonia (VAP) is critical but can lead to overdiagnosis and overtreatment.Objectives:We investigated healthcare provider (HCP) perceptions and challenges associated with VAP dia
Autor:
Jean A. Yared, Elizabeth Hutnick, Ashraf Badros, Mehmet H. Kocoglu, Nancy M. Hardy, Forat Lutfi, Søren M. Bentzen, Jonathan Siglin, Aaron P. Rapoport, Firas El Chaer, Carl Shanholtz, Kathleen Ruehle, Vivek Kesari, Noa G. Holtzman, Hao Xie, Haroon Ahmad, Saurabh Dahiya, Ali Bukhari, Natalie Gahres
Publikováno v:
Neuro Oncol
Background CD19-directed chimeric antigen receptor (CAR) T-cell therapy (CAR-T) has emerged as effective for relapsed/refractory large B-cell lymphoma (R/R LBCL). The neurologic toxicity seen with CAR-T, referred to as immune effector cell–associat
Autor:
Matthew A. Warner, Daryl J. Kor, Ryan D. Frank, Cheryl Dennison Himmelfarb, Victor D. Dinglas, Curtis B. Storlie, Dale M. Needham, Pedro A. Mendez-Tellez, Carl Shanholtz
Publikováno v:
Journal of Intensive Care Medicine. 36:557-565
Objective: Anemia is common during critical illness and often persists after hospital discharge; however, its potential association with physical outcomes after critical illness is unclear. Our objective was to assess the associations between hemoglo
Autor:
Laura Seiberlich, Thelma Harrington, Giora Netzer, Debbi Child, Peter Kratz, Jeffrey P. Gonzales, Carl Shanholtz
Publikováno v:
The Annals of pharmacotherapy. 56(1)
Background: Positive fluid balance early in critical illness is associated with poor outcomes. Reducing intravenous medication volume may mitigate volume overload. Objective: Assessment of fluid and medication administration and clinical outcomes in
Autor:
Wesley H. Self, Thomas G. Stewart, Allison P. Wheeler, Wissam El Atrouni, Amanda J. Bistran-Hall, Jonathan D. Casey, Vince D. Cataldo, James D. Chappell, Claudia S. Cohn, Jessica B. Collins, Mark R. Denison, Marjolein de Wit, Sheri L. Dixon, Abhijit Duggal, Terri L. Edwards, Magali J. Fontaine, Adit A. Ginde, Michelle S. Harkins, Thelma Harrington, Estelle S. Harris, Daanish Hoda, Tina S. Ipe, Stuti J. Jaiswal, Nicholas J. Johnson, Alan E. Jones, Maryrose Laguio-Vila, Christopher J. Lindsell, Jason Mallada, Manoj J. Mammen, Ryan A. Metcalf, Elizabeth A. Middleton, Simon Mucha, Hollis R. O’Neal, Sonal R. Pannu, Jill M. Pulley, Xian Qiao, Jay S. Raval, Jillian P. Rhoads, Harry Schrager, Carl Shanholtz, Nathan I. Shapiro, Stephen J. Schrantz, Isaac Thomsen, Krista K. Vermillion, Gordon R. Bernard, Todd W. Rice, For the Passive Immunity Trial for Our Nation (PassITON) Investigators
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-13 (2021)
Trials
Research Square
article-version (status) pre
article-version (number) 1
Trials
Research Square
article-version (status) pre
article-version (number) 1
Background Convalescent plasma is being used widely as a treatment for coronavirus disease 2019 (COVID-19). However, the clinical efficacy of COVID-19 convalescent plasma is unclear. Methods The Passive Immunity Trial for Our Nation (PassITON) is a m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::497ca2964f35cfb2ca2977ed143f398c
https://doi.org/10.21203/rs.3.rs-227796/v1
https://doi.org/10.21203/rs.3.rs-227796/v1
Autor:
Saurabh Dahiya, Carl Shanholtz, Aaron P. Rapoport, Noa G. Holtzman, Forat Lutfi, Jonathan Siglin, Jean A. Yared, Ali Bukhari, Nancy M. Hardy
Publikováno v:
Leukemialymphoma. 61(9)
Chimeric antigen receptor T-cell(CAR-T) therapy is an increasingly utilized treatment modality with FDA approval for relapsed or refractory(R/R) CD19 positive B-cell Acute Lymphoblastic Leukemia(B-...
Autor:
Kimberly C. Claeys, Surbhi Leekha, Mary Richert, Carl Shanholtz, Andrea G. Shipper, Blaine Kenaa, Lyndsay M. O’Hara, Gregory M. Schrank, Kaede V. Sullivan, Daniel J. Morgan
Publikováno v:
Current infectious disease reports. 21(12)
Ventilator-associated pneumonia (VAP) is one of the most common infections in the ICU. Prompt diagnosis is vital as mortality increases with delayed antibiotic therapy. However, accurate diagnosis is challenging due to non-specific clinical features
Autor:
Neal Dodia, Diana E. Amariei, Mary Richert, Ellen T Marciniak, Michael L. Terrin, Charlene C. Quinn, Carl Shanholtz, Clayton H. Brown, Andrew R. Deitchman, Jeffrey D. Hasday
Publikováno v:
Respiratory care. 65(3)
BACKGROUND: Our Cooling to Help Injured Lungs (CHILL) trial of therapeutic hypothermia in ARDS includes neuromuscular blockade (NMB) as an inclusion criterion to avoid shivering. NMB has been used to facilitate mechanical ventilation in ARDS and was
Autor:
Giora Netzer, Neil R. Aggarwal, Roy G. Brower, B. Taylor Thompson, Carl Shanholtz, Adrian Lagakos, David N. Hager, William Checkley
Publikováno v:
Critical Care Medicine. 46:517-524
High fractions of inspired oxygen may augment lung damage to exacerbate lung injury in patients with acute respiratory distress syndrome. Participants enrolled in Acute Respiratory Distress Syndrome Network trials had a goal partial pressure of oxyge